Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model.

ABSTRACT:

SUBMITTER: Zeng T 

PROVIDER: S-EPMC11583811 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature